Blood tests to study a new protein in heart disease
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study looks at blood levels of total protein and albumin, along with routine blood tests, to better understand a new protein and its role in disease. It may help researchers find early clues about what’s going on in the body, though it’s primarily a diagnostic and research effort.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be able to have blood drawn for routine blood tests
- Have blood tests for total protein and albumin
- Have triglycerides (a blood fat) not higher than 5.00 mmol/L
- Have bilirubin not higher than 170 mmol/L
- Not be using fat emulsion in the last 3 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is screening people over 30 to find a protein in the blood called M protein, which can be a sign of certain blood conditions. If you have it, the study will follow you over time to learn more.
This study looks at stored blood (serum) samples to see whether a lab test called MALDI-TOF mass spectrometry can help analyze multiple myeloma proteins. If you have multiple myeloma (or are a healthy matched control), your existing lab samples may be used for testing.
This trial studies myeloma (and closely related blood disorders) by using extra blood or bone marrow samples for lab research. It aims to help discover new ways to understand or treat myeloma.
This study checks if a protein change in your blood can help predict how your blood cancer will respond to treatment. It is for adults with a blood cancer who are about to start therapy.
This study measures how well the heart’s tiny blood vessels work in people with cardiac amyloidosis, using special heart testing. It may help doctors understand the disease better and improve how patients are evaluated over time.
This study is looking for people who have had a heart attack or have heart failure to discover new markers in your blood that could help doctors better understand and treat heart disease. By collecting samples and health data, researchers hope to find clues that improve care for future patients.
Hear when a new Cardiac Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.